Company / Working Capital per Share
Axsome Therapeutics, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$4.32
FY2025
5-year range
$1.69 / $8.40
FY2021-FY2025
Trend
-19.8%
vs FY2024
Sector context
#118 of 210
Health Care
What the data says
At $4.32, Axsome Therapeutics, Inc.'s working capital per share ranks #118 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $0.16 in FY2018 to $8.40 in FY2023.
Based on SEC 10-K filings.
4.32 in FY2025 with a 5-year CAGR of +0.0%.
Declined from $8.40 to $4.32 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- +0.0%
- 10-Year CAGR
- -
Sector benchmark
#118 of 210 in Health CareTop 56% of 210This company $4.32 Sector average $146.86
▼
-97.1% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 19.8% year-over-year.
- Ranks #118 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2023.
- Lowest working capital per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.32 | -19.8% |
| FY2024 | $5.38 | -35.9% |
| FY2023 | $8.40 | +113.1% |
| FY2022 | $3.94 | +133.7% |
| FY2021 | $1.69 | -60.9% |
| FY2020 | $4.32 | -25.0% |
| FY2019 | $5.76 | +3423.5% |
| FY2018 | $0.16 | -83.9% |
| FY2017 | $1.02 | -36.9% |
| FY2016 | $1.61 | -58.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026